Neumirna Therapeutics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $21M
Investors
- 3
About Neumirna Therapeutics
Founded in 2020, and based in Copenhagen, Denmark, Neumirna Therapeutics ApS operates as a pharmaceutical company that engages in the development of RNA therapies. The company's RNA therapies effectively modifies the course of neurological disorders, including epilepsy.001, targets specific molecular pathways involved in these conditions. The company employs advanced RNA therapeutic technologies to create transformative solutions for patients requiring disease modification, with end users primarily being patients suffering from various neurological disorders.
Who invested in Neumirna Therapeutics
3 investors across 1 round
See all investors in Neumirna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 8, 2025
Amount
$21M
Investors
Questions about Neumirna Therapeutics
Who invested in Neumirna Therapeutics?
Neumirna Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neumirna Therapeutics raised?
Neumirna Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neumirna Therapeutics last raise money?
Neumirna Therapeutics's most recent round on record is a Series A, in Jan 2025.
What does Neumirna Therapeutics do?
Founded in 2020, and based in Copenhagen, Denmark, Neumirna Therapeutics ApS operates as a pharmaceutical company that engages in the development of RNA therapies.
Where is Neumirna Therapeutics headquartered?
Neumirna Therapeutics is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Neumirna Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Neumirna Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Neumirna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.